GlassScriptPhysician profile
David M Cykert
NPI 1154777456
$8,725.04
in general payments reported to CMS, 2019-2025
59 companies · $2,329 in 2025
The $2,329 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $291 · 2021: $995 · 2022: $1,025 · 2023: $1,664 · 2024: $2,114 · 2025: $2,329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,934 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,933.72 |
| Education | $173.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,604.82 | 2021-2025 | Linzess, Creon, Ubrelvy |
| Pfizer INC. | $825.63 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $503.15 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Astellas Pharma US INC | $453.64 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $440.94 | 2019-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $423.60 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $328.11 | 2021-2025 | |
| Exact Sciences Corporation | $316.04 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $271.54 | 2019-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $256.44 | 2019-2023 | Trintellix |
| Sumitomo Pharma America, INC. | $244.16 | 2023-2025 | Gemtesa |
| Lilly USA, LLC | $228.30 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Dexcom, INC. | $216.05 | 2021-2025 | Dexcom G6 Transmitter |
| Abbott Laboratories | $167.36 | 2021-2025 | Freestyle Libre 3 |
| Amarin Pharma, INC. | $161.49 | 2020-2022 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $151.12 | 2022-2025 | Jardiance |
| Inari Medical, INC. | $138.85 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Bayer Healthcare Pharmaceuticals INC. | $136.09 | 2021-2025 | |
| Daiichi Sankyo INC. | $130.89 | 2021-2025 | Injectafer |
| Esperion Therapeutics, INC. | $118.18 | 2020-2025 | Nexletol |
| Neurocrine Biosciences, INC. | $114.96 | 2024-2025 | Ingrezza |
| Kowa Pharmaceuticals America, INC. | $104.98 | 2020-2025 | Zoryve |
| Verona Pharma, INC. | $97.84 | 2025 | Ohtuvayre |
| Eisai INC. | $89.12 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $77.35 | 2023-2025 | Rexulti |
| Stryker Corporation | $73.22 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $65.20 | 2025 | Caplyta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $63.89 | 2019-2023 | Xifaxan |
| Axsome Therapeutics, INC. | $58.56 | 2025 | Symbravo, Auvelity |
| Biohaven Pharmaceutical Holding Company LTD. | $55.79 | 2022 | |
| Lundbeck LLC | $52.71 | 2025 | Rexulti |
| Sanofi-Aventis U.S. LLC | $48.07 | 2021-2023 | |
| Shield Therapeutics INC | $47.63 | 2024-2025 | |
| Corium, LLC | $46.92 | 2022-2023 | Azstarys |
| Merck Sharp & Dohme LLC | $44.50 | 2021-2025 | Capvaxive, Gardasil 9 |
| Medtronic, INC. | $43.90 | 2024-2025 | Intellis Adaptivestim |
| Halozyme INC | $41.94 | 2023 | |
| Phathom Pharmaceuticals, INC. | $36.18 | 2025 | Voquezna |
| Antares Pharma, INC. | $34.23 | 2024-2025 | Xyosted |
| Tolmar, INC. | $33.61 | 2025 | Jatenzo |
| Genentech USA, INC. | $31.44 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $31.26 | 2025 | Purified Cortrophin Gel |
| Edwards Lifesciences Corporation | $28.44 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Idorsia Pharmaceuticals US INC | $26.59 | 2023 | Quviviq |
| Vifor Pharma, INC. | $25.97 | 2024 | Veltassa |
| Recor Medical INC | $24.82 | 2025 | Paradise Ultrasound Renal Denervation System |
| Biohaven Pharmaceuticals, INC. | $22.41 | 2021 | |
| Inspire Medical Systems, INC. | $19.62 | 2025 | Inspire |
| Xeris Pharmaceuticals, INC. | $18.62 | 2023 | Gvoke Hypopen |
| Philips North America LLC | $17.41 | 2021 | |
| Boston Scientific Corporation | $17.27 | 2022 | |
| Ironwood Pharmaceuticals, INC | $16.78 | 2021 | |
| Acadia Pharmaceuticals INC | $16.54 | 2021 | |
| Dynavax Technologies Corporation | $15.83 | 2024 | Heplisav-B |
| Upsher-Smith Laboratories LLC | $14.25 | 2022 | |
| Tonix Medicines, INC. | $14.09 | 2025 | Tonmya |
| Teva Pharmaceuticals USA, INC. | $13.15 | 2022 | |
| Ibsa Pharma INC. | $12.02 | 2021 | |
| Janssen Pharmaceuticals, INC | $11.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cykert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.